Oscar Health (NYSE:OSCR) Stock Price Up 4.1%

Oscar Health, Inc. (NYSE:OSCR)’s share price rose 4.1% on Wednesday . The company traded as high as $14.56 and last traded at $14.56. Approximately 283,240 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 3,217,866 shares. The stock had previously closed at $13.99.

Analyst Upgrades and Downgrades

OSCR has been the subject of a number of analyst reports. Raymond James began coverage on shares of Oscar Health in a research report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 target price for the company. The Goldman Sachs Group increased their price target on shares of Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a research note on Friday, February 9th. Wells Fargo & Company increased their price target on shares of Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. Finally, TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a research note on Wednesday, February 21st. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $13.50.

Oscar Health Stock Up 0.5 %

The business’s 50 day moving average price is $15.15 and its 200-day moving average price is $10.41. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.74) by $0.08. The company had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. Oscar Health’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same quarter last year, the company posted ($1.05) EPS. As a group, equities research analysts expect that Oscar Health, Inc. will post -0.23 earnings per share for the current year.

Institutional Trading of Oscar Health

A number of hedge funds have recently modified their holdings of OSCR. Dark Forest Capital Management LP raised its stake in Oscar Health by 5,243.2% in the 1st quarter. Dark Forest Capital Management LP now owns 7,801 shares of the company’s stock worth $51,000 after purchasing an additional 7,655 shares in the last quarter. Prevail Innovative Wealth Advisors LLC acquired a new stake in Oscar Health in the 4th quarter worth about $92,000. Advisor Group Holdings Inc. raised its stake in Oscar Health by 157.5% in the 1st quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company’s stock worth $101,000 after purchasing an additional 6,182 shares in the last quarter. Royal Bank of Canada raised its stake in Oscar Health by 959.5% in the 3rd quarter. Royal Bank of Canada now owns 10,129 shares of the company’s stock worth $50,000 after purchasing an additional 9,173 shares in the last quarter. Finally, Gotham Asset Management LLC acquired a new stake in Oscar Health in the 1st quarter worth about $70,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.